Literature DB >> 18388926

The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver.

Anton P McCaffrey1, Paul Fawcett, Hiroyuki Nakai, Ramona L McCaffrey, Anja Ehrhardt, Thu-Thao T Pham, Kusum Pandey, Hui Xu, Sally Feuss, Theresa A Storm, Mark A Kay.   

Abstract

Understanding host responses to viral gene therapy vectors is necessary for the development of safe and efficacious in vivo gene transfer agents. We describe the use of high-density spotted complementary DNA microarrays in monitoring the in vivo host transcriptional responses in mouse liver upon administration of either a "first-generation"adenoviral (Ad) vector, a helper-dependent "gutless" adenoviral (HD) vector, or an adeno-associated viral (AAV) vector containing human factor IX (hFIX) expression cassettes. Since HD and AAV do not contain any viral genes, they allow us to assess the host response to the viral capsid and packaged nonviral DNA in whole animals. Comparison of the host response to Ad and HD helps assess the importance of leaky adenoviral gene expression. While all three vectors induced characteristic temporally sequenced programs of gene expression, the gene expression programs induced by the Ad and HD adenovirus vectors were remarkably similar, including the induction of a prominent type I interferon (IFN)-dependent cluster within 6 hours of administration. In contrast, the AAV-based vector caused far fewer alterations of host-gene expression. Our results indicate that recognition of the Ad capsid or double-stranded DNA (of nonviral origin) in the vector elicits a robust type I IFN response that is, however, not elicited by AAV-derived vector transduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388926     DOI: 10.1038/mt.2008.37

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  51 in total

Review 1.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

Review 2.  Innate immune recognition of viruses and viral vectors.

Authors:  Xiaopei Huang; Yiping Yang
Journal:  Hum Gene Ther       Date:  2009-04       Impact factor: 5.695

Review 3.  Gene therapy vectors: the prospects and potentials of the cut-and-paste transposons.

Authors:  Corentin Claeys Bouuaert; Ronald M Chalmers
Journal:  Genetica       Date:  2009-08-02       Impact factor: 1.082

4.  DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.

Authors:  Tomoya Terashima; Kazuhiro Oka; Angelika B Kritz; Hideto Kojima; Andrew H Baker; Lawrence Chan
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

5.  Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.

Authors:  Piyanuch Wonganan; Kristina Jonsson-Schmunk; Shellie M Callahan; Jin Huk Choi; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

Review 6.  State-of-the-art gene-based therapies: the road ahead.

Authors:  Mark A Kay
Journal:  Nat Rev Genet       Date:  2011-04-06       Impact factor: 53.242

7.  NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.

Authors:  Masataka Suzuki; Racel Cela; Terry K Bertin; Gautam Sule; Vincenzo Cerullo; John R Rodgers; Brendan Lee
Journal:  Hum Gene Ther       Date:  2011-07-08       Impact factor: 5.695

Review 8.  Progress and prospects: immune responses to viral vectors.

Authors:  S Nayak; R W Herzog
Journal:  Gene Ther       Date:  2009-11-12       Impact factor: 5.250

9.  Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells.

Authors:  Arpita S Bharadwaj; Meagan Kelly; Dongsoo Kim; Hengjun Chao
Journal:  Blood       Date:  2009-11-17       Impact factor: 22.113

10.  Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.

Authors:  Sadik H Kassim; Hui Li; Luk H Vandenberghe; Christian Hinderer; Peter Bell; Dawn Marchadier; Aisha Wilson; Debra Cromley; Valeska Redon; Hongwei Yu; James M Wilson; Daniel J Rader
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.